Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2020 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, June 13, 2020 to consider and approve the audited financial Statements of the Company for the quarter and year ended March 31, 2020. We further wish to inform you that in terms of the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in securities of the Company has been closed with effect from April 01, 2020 and shall re-open 48 hours after the financial results are made public. We request you to take the same on your records. Thanking you,
07-06-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Non-Applicability Of SEBI Circular No. Sebl/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018 With Regard To Fund Raising By Issuance Of Debt Securities By Large Entities

 With reference to above SEBI Circular, we would like to inform you that our company - Aspira Pathlab & Diagnostics Limited is "Not a Large Corporate" as per the framework provided in the aforesaid Circular. Kindly take the above in your records.
14-05-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2020

 We are enclosing herewith a certificate for half-year ended March 31, 2020, duly signed by Mr. S.K. Pandey, Practicing Company Secretaries, pursuant to the provisions under Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly acknowledge the receipt, and please take the same on record.
05-05-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2020

 We are enclosing herewith a certificate for half-year ended March 31, 2020, duly signed by Mr. S.K. Pandey, Practicing Company Secretaries, pursuant to the provisions under Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly acknowledge the receipt, and please take the same on record.
05-05-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 For The Half Year Ended March 31, 2020

 We are enclosing herewith Compliance certificate under Regulation 7(3) of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 for the half year ended March 31, 2020.
01-05-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended March 31, 2020

 Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
24-04-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the certificate dated April 08, 2020, received from M/S. Sharex Dynamic (India) Pvt. Ltd. the Registrar and Transfer Agent of the Company, for the quarter ended March 31, 2020. We request you to kindly take above on the records. Due to the prevailing situation, this intimation is being filed under sd/- Thanking you.
20-04-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the certificate dated April 08, 2020, received from M/S. Sharex Dynamic (India) Pvt. Ltd. the Registrar and Transfer Agent of the Company, for the quarter ended March 31, 2020. We request you to kindly take above on the records. Due to the prevailing situation, this intimation is being filed under sd/- Thanking you.
20-04-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, this is to inform you that Mr. Ravindra Desai, Chief Executive Officer (Key managerial Personnel) of Aspira Pathlab & Diagnostics Limited has tendered his resignation w.e.f April 19, 2020. The Managing Director of the Company has accepted the same and accordingly Mr. Ravindra Desai will be relieved from the position of Chief Executive Officer of Aspira Pathlab & Diagnostics Limited effective from April 19, 2020. We request you to take the same on your records and disseminate the same to the members.
20-04-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mamta MavDesignation :- Company Secretary and Compliance Officer
20-04-2020
Next Page
Close

Let's Open Free Demat Account